Cumberland Pharmaceuticals INC (CPIX) — 10-Q Filings

All 10-Q filings from Cumberland Pharmaceuticals INC. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Cumberland Pharma's Q3 Loss Widens, 9-Month Revenue Up 12.4% — Nov 7, 2025 Risk: high
Cumberland Pharmaceuticals Inc. reported a net loss of $1,940,764 for the three months ended September 30, 2025, an increase from a net loss of $1,544,081 in th
Cumberland Pharma's Q2 Net Loss Widens to $1.1M Amid Revenue Dip — Aug 8, 2025 Risk: high
Cumberland Pharmaceuticals Inc. reported a net loss of $1.1 million for the three months ended June 30, 2025, a significant increase from the $0.3 million net l
Cumberland Pharmaceuticals Files Q1 2025 10-Q — May 9, 2025 Risk: low
Cumberland Pharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position as of Q
Cumberland Pharmaceuticals Files Q3 2024 10-Q — Nov 8, 2024 Risk: medium
Cumberland Pharmaceuticals Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for th
Cumberland Pharmaceuticals Files Q2 2024 10-Q — Aug 9, 2024 Risk: medium
Cumberland Pharmaceuticals Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the sec
Cumberland Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk: low
CUMBERLAND PHARMACEUTICALS INC (CPIX) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Cumberland Pharmaceuticals Inc. filed a 10-Q report for the

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX